Warning: ereg(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'Europe/London' for 'BST/1.0/DST' instead in /home/searchgo/public_html/app/app.class.php on line 43 Deprecated: Function ereg() is deprecated in /home/searchgo/public_html/app/app.class.php on line 43 Roche extends Illumina offer until late March - Business news - Search and Go
Warning: eregi_replace(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'Europe/London' for 'BST/1.0/DST' instead in /home/searchgo/public_html/app/app.class.php on line 1195 Deprecated: Function eregi_replace() is deprecated in /home/searchgo/public_html/app/app.class.php on line 1195

Roche extends Illumina offer until late March

<p><a href="http://uk.news.yahoo.com/roche-extends-illumina-offer-until-march-062307323.html"><img src="http://l.yimg.com/bt/api/res/1.2/pv_kwFAS6Jqjrbl5u7IDgQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2012-02-27T062307Z_1_BTRE81Q0HQM00_RTROPTP_2_ROCHE.JPG" width="130" height="86" alt="The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf" align="left" title="The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf" border="0" /></a>ZURICH (Reuters) - Roche on Monday extended its $5.7 billion (3.5 billion pound) hostile offer for Illumina until March 23, a move that was widely expected as the Swiss drugmaker is keen to boost its position in the gene sequencing market. "All other terms and conditions of the offer remain unchanged," Basel-based Roche said in a statement. Illumina has already adopted a "poison pill" defence strategy for Roche's unsolicited of $44.50 per share bid. It told shareholders not to tender any of their shares to Roche, saying the offer failed to properly value its existing and coming products. ...</p><br clear="all"/>

Click here to read the rest of this article.

Add to: Add to Delicious del.cio.us, Add to Digg Digg, Add to Yahoo Yahoo!, Add to Google Google

Other articles in the Business news section

Google Boss Urges 'Reasonable' Debate... 3 hours ago

The executive chairman of... ...more

Arab spring nations face delayed economic... 4 hours ago

By Suleiman Al-Khalidi AMMAN (Reuters) - Arab spring countries face rising social tensions that could thwart an early economic recovery from over two years of political turmoil that has worsened fiscal ...more

WPP Wins Crucial Backing Over Pay Reforms... 10 hours ago

WPP, the world's biggest marketing services group... ...more

Loro Piana rides high through recession... 12 hours ago

By Naomi O'Leary ROME (Reuters) - Italian luxury firm Loro Piana expects double-digit sales growth to continue in 2013 as it expands its niche in the ultra-luxury sector, its chief executive told Reuters on Friday. Pier Luigi Loro Piana said barring major upsets, sales should grow a little over 10 percent this year, after growth of 13.1 percent to 630 million euros (£538.7 million) in 2012. ... ...more

Blackstone notifies Cohen's SAC it intends... 12 hours ago

By Matthew Goldstein (Reuters) - Billionaire hedge fund manager Steven A. Cohen is losing the financial support of Blackstone Group Inc , the largest outside investor in his embattled SAC Capital Advisors ...more

Apple 1 Computer Sells For Record At... 13 hours ago

One of only six surviving Apple... ...more

Other news